ARTICLES
Should we dream the impossible dream? The meaning of long-term survival in metastatic breast cancer
GW Sledge, Jr
JCO Aug 1 1996: 2191–2193. [PDF]
Autologous stem-cell transplantation and purging
B Lowenberg and P Voogt
JCO Aug 1 1996: 2194–2196. [PDF]
	Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer
	PA Greenberg, GN Hortobagyi, TL Smith, LD Ziegler, DK Frye, and AU Buzdar
	JCO Aug 1 1996: 2197–2205. [Abstract] [PDF]
	In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission
	AS Stein, MR O'Donnell, A Chai, GM Schmidt, A Nademanee, PM Parker, EP Smith, DS Snyder, A Molina, DE Stepan, R Spielberger, G Somlo, KA Margolin, N Vora, J Lipsett, J Lee, J Niland, and SJ Forman
	JCO Aug 1 1996: 2206–2216. [Abstract] [PDF]
	Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: a single-institute study of 96 patients
	E Vaccher, U Tirelli, M Spina, R Talamini, D Errante, C Simonelli, and A Carbone
	JCO Aug 1 1996: 2217–2223. [Abstract] [PDF]
	Highly purified CD34-positive cells reconstitute hematopoiesis
	CI Civin, T Trischmann, NS Kadan, J Davis, S Noga, K Cohen, B Duffy, I Groenewegen, J Wiley, P Law, A Hardwick, F Oldham, and A Gee
	JCO Aug 1 1996: 2224–2233. [Abstract] [PDF]
	Phase I study of subcutaneously administered interleukin-2 in combination with interferon alfa-2a in patients with advanced cancer
	BL Gause, M Sznol, WC Kopp, JE Janik, JW Smith, 2nd, RG Steis, WJ Urba, W Sharfman, RG Fenton, SP Creekmore, J Holmlund, KC Conlon, LA VanderMolen, and DL Longo
	JCO Aug 1 1996: 2234–2241. [Abstract] [PDF]
	Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Emesis Prevention Group
	P Hesketh, R Navari, T Grote, R Gralla, J Hainsworth, M Kris, L Anthony, A Khojasteh, E Tapazoglou, C Benedict, and W Hahne
	JCO Aug 1 1996: 2242–2249. [Abstract] [PDF]
	Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol
	A Chang, B Yeap, T Davis, R Blum, R Hahn, O Khanna, H Fisher, J Rosenthal, R Witte, R Schinella, and D Trump
	JCO Aug 1 1996: 2250–2257. [Abstract] [PDF]
	Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas
	FJ Fowler, Jr, MJ Barry, G Lu-Yao, JH Wasson, and L Bin
	JCO Aug 1 1996: 2258–2265. [Abstract] [PDF]
	Modulation of high-dose infusional fluorouracil by low-dose methotrexate in patients with advanced or metastatic colorectal cancer: final results of a randomized European Organization for Research and Treatment of Cancer Study
	G Blijham, T Wagener, J Wils, J de Greve, M Buset, H Bleiberg, A Lacave, M Dalmark, J Selleslag, L Collette, and T Sahmoud
	JCO Aug 1 1996: 2266–2273. [Abstract] [PDF]
	Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial.Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1
	E Jager, M Heike, H Bernhard, O Klein, G Bernhard, D Lautz, J Michaelis, KH Meyer zum Buschenfelde, and A Knuth
	JCO Aug 1 1996: 2274–2279. [Abstract] [PDF]
	Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancer. Colorectal Cancer Working Party of the United Kingdom Medical Research Council
	MT Seymour, ML Slevin, DJ Kerr, D Cunningham, RD James, JA Ledermann, TJ Perren, WA McAdam, PG Harper, JP Neoptolemos, M Nicholson, AM Duffy, RJ Stephens, SP Stenning, and I Taylor
	JCO Aug 1 1996: 2280–2288. [Abstract] [PDF]
	Lymph node retrieval in a randomized trial on western-type versus Japanese-type surgery in gastric cancer
	AM Bunt, J Hermans, CJ van de Velde, M Sasako, FA Hoefsloot, G Fleuren, and JA Bruijn
	JCO Aug 1 1996: 2289–2294. [Abstract] [PDF]
	Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group
	FL Moffat, Jr, CM Pinsky, L Hammershaimb, NJ Petrelli, YZ Patt, FS Whaley, and DM Goldenberg
	JCO Aug 1 1996: 2295–2305. [Abstract] [PDF]
	Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas
	DV Jones, Jr, R Lozano, A Hoque, A Markowitz, and YZ Patt
	JCO Aug 1 1996: 2306–2310. [Abstract] [PDF]
	Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract cancer
	YZ Patt, DV Jones, Jr, A Hoque, R Lozano, A Markowitz, I Raijman, P Lynch, and C Charnsangavej
	JCO Aug 1 1996: 2311–2315. [Abstract] [PDF]
	Phase II study of paclitaxel in patients with recurrent malignant glioma
	MD Prados, SC Schold, AM Spence, MS Berger, LD McAllister, MP Mehta, MR Gilbert, D Fulton, J Kuhn, K Lamborn, DJ Rector, and SM Chang
	JCO Aug 1 1996: 2316–2321. [Abstract] [PDF]
	Chemotherapy followed by accelerated fractionated radiation for larynx preservation in patients with advanced laryngeal cancer
	A Eisbruch, AF Thornton, S Urba, RM Esclamado, WR Carroll, CR Bradford, MB Hazuka, FJ Littles, M Strawderman, and GT Wolf
	JCO Aug 1 1996: 2322–2330. [Abstract] [PDF]
	Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results
	O Laccourreye, D Brasnu, V Bassot, M Menard, D Khayat, and H Laccourreye
	JCO Aug 1 1996: 2331–2336. [Abstract] [PDF]
	Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party
	JP Sculier, M Paesmans, G Bureau, V Giner, J Lecomte, J Michel, MC Berchier, O Van Cutsem, U Kustner, F Kroll, R Sergysels, P Mommen, and J Klastersky
	JCO Aug 1 1996: 2337–2344. [Abstract] [PDF]
	Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial
	JH Schiller, K Kim, P Hutson, R DeVore, J Glick, J Stewart, and D Johnson
	JCO Aug 1 1996: 2345–2352. [Abstract] [PDF]
	Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma
	PS Gill, J Wernz, DT Scadden, P Cohen, GM Mukwaya, JH von Roenn, M Jacobs, S Kempin, I Silverberg, G Gonzales, MU Rarick, AM Myers, F Shepherd, C Sawka, MC Pike, and ME Ross
	JCO Aug 1 1996: 2353–2364. [Abstract] [PDF]
	Radiation in management of patients with dermatofibrosarcoma protuberans
	H Suit, I Spiro, HJ Mankin, J Efird, and AE Rosenberg
	JCO Aug 1 1996: 2365–2369. [Abstract] [PDF]
	Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia
	C Ito, WE Evans, L McNinch, E Coustan-Smith, H Mahmoud, CH Pui, and D Campana
	JCO Aug 1 1996: 2370–2376. [Abstract] [PDF]
	Bronchioloalveolar carcinoma
	JE Barkley and MR Green
	JCO Aug 1 1996: 2377–2386. [Abstract] [PDF]
American Society of Clinical Oncology: a society in transition
JH Glick
JCO Aug 1 1996: 2388–2398. [PDF]
Tumor size and prognosis in aggressively treated osteosarcoma
N Jaffe and DM Jaffe
JCO Aug 1 1996: 2399–2400. [PDF]
Microvascular count and prognosis in colorectal cancer
LY Dirix, PB Vermeulen, AT Van Oosterom, and G Gasparini
JCO Aug 1 1996: 2400–2403. [PDF]
Cytoreduction and prognosis in childhood acute lymphoblastic leukemia
M Schrappe, A Reiter, and H Riehm
JCO Aug 1 1996: 2403–2406. [PDF]
Relationship of histologic grade, c-erbB-2 expression, and inflammatory infiltrate to prognosis in carcinoma of the breast
AH Lee and LG Bobrow
JCO Aug 1 1996: 2406–2407. [PDF]
Antiestrogens and the reduction in circulating cholesterol
VC Jordan
JCO Aug 1 1996: 2407–2408. [PDF]
Extended lymph node dissection in gastric cancer induces substantial stage migration and increases stage-specific survival without improvement of overall survival
D Roukos, A Lazaros, A Kappas, and A Encke
JCO Aug 1 1996: 2408–2410. [PDF]
Long-term response data for 255 patients with metastatic renal cell carcinoma treated with high-dose recombinant interleukin-2 therapy
GA Fyfe, RI Fisher, SA Rosenberg, M Sznol, DR Parkinson, and AC Louie
JCO Aug 1 1996: 2410–2411. [PDF]

SPECIAL DEPARTMENTS
Errata
	Transdermal Clonidine for Ameliorating Tamoxifen-Induced Hot Flashes
	Richard M. Goldberg, Charles L. Loprinzi, Judith R. O'Fallon, Michael H. Veeder, Angela W. Miser, James A. Mailliard, John C. Michalak, Ann Marie Dose, Ken M. Rowland, Jr, and Nora L. Burnham
	JCO Aug 1 1996: 2411. [Abstract] [PDF]
	Loss of Heterozygosity of the RB Gene Is a Poor Prognostic Factor in Patients With Osteosarcoma
	Olivier Feugeas, Nathalie Guriec, Annie Babin-Boilletot, Luc Marcellin, Patrick Simon, Serge Babin, Antoine Thyss, Patrick Hofman, Philippe Terrier, Chantal Kalifa, Maud Brunat-Mentigny, Louis-Marie Patricot, and Francis Oberling
	JCO Aug 1 1996: 2411-a. [Abstract] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.